USD 17.85
(0.56%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 658.35 Million | 1.02 Billion | 1.16 Billion | 748.92 Million | 301.88 Million | 250.92 Million |
Net Income | -23.62 Million | 144.6 Million | 424.1 Million | 219.96 Million | -83.01 Million | 78.57 Million |
Depreciation & Amortization | 456.62 Million | 616 Million | 648.7 Million | 260.56 Million | 197.21 Million | 169.06 Million |
Deferred income taxes | -1.06 Billion | 212.3 Million | -13.5 Million | 118.89 Million | 108.89 Million | -45.29 Million |
Stock-based compensation | 28.7 Million | 32.8 Million | 32.5 Million | 18.8 Million | 21.04 Million | 24.93 Million |
Change in working capital | -129.22 Million | -91.6 Million | 8.2 Million | 81.89 Million | 7.88 Million | -10.08 Million |
Other non-cash items | 1.39 Billion | 107.9 Million | 66.1 Million | 48.83 Million | 49.85 Million | 33.72 Million |
Investing Cash Flow | -835.85 Million | -521.4 Million | -511.7 Million | -160.11 Million | -251.52 Million | -453.31 Million |
Investments in PPE | -776.58 Million | -518.3 Million | -522.5 Million | -241.28 Million | -233.89 Million | -402.2 Million |
Acquisitions | 17.82 Million | 2.2 Million | 22.3 Million | 92.98 Million | 3.5 Million | 31.48 Million |
Investment purchases | -10.18 Million | 518.3 Million | - | - | - | - |
Sales/Maturities of investments | - | 10.7 Million | - | - | - | - |
Other Investing Activities | -66.9 Million | -534.3 Million | -11.5 Million | -11.8 Million | -21.13 Million | -51.11 Million |
Financing Cash Flow | -281.67 Million | -385 Million | -431.1 Million | -70.71 Million | 15.12 Million | 204.46 Million |
Debt repayment | -176.78 Million | -50 Million | -1.14 Billion | -150 Million | -79.64 Million | -238.79 Million |
Dividends payments | -204.07 Million | -159.99 Million | -128.75 Million | - | - | - |
Common Stock Repurchased | -81.36 Million | -128.1 Million | -134.9 Million | - | - | - |
Common Stock Issuance | 6 Million | 21.2 Million | 200 Million | 100 Million | 292 Thousand | 569.4 Thousand |
Other Financing Activities | 174.54 Million | -61.5 Million | 776.7 Million | -20.71 Million | 94.47 Million | -34.33 Million |
Accounts receivables | -81.87 Million | -13.06 Million | -4.26 Million | 4.31 Million | 21.68 Million | -4.73 Million |
Accounts payables | -6.41 Million | -10.17 Million | -63.53 Million | 44.95 Million | 8.42 Million | 6.19 Million |
Inventory | -38.39 Million | -57.5 Million | 65.2 Million | 45.13 Million | -10.79 Million | -17.19 Million |
Other working capital | -2.54 Million | -10.85 Million | 10.79 Million | -12.51 Million | -11.43 Million | 11.84 Million |
Cash at beginning of period | 950.66 Million | 906.2 Million | 714.7 Million | 189.88 Million | 124.02 Million | 122.7 Million |
Cash at end of period | 514.55 Million | 951.1 Million | 906.2 Million | 644.97 Million | 189.88 Million | 124.02 Million |
Capital Expenditure | -776.58 Million | -518.3 Million | -522.5 Million | -241.28 Million | -233.89 Million | -402.2 Million |
Effect of forex changes on cash | 17 Million | -70.7 Million | -31.8 Million | 6.68 Million | 384 Thousand | -748 Thousand |
Net cash flow / Change in cash | -436.11 Million | 44.9 Million | 191.5 Million | 455.08 Million | 65.86 Million | 1.32 Million |
Free Cash Flow | -118.22 Million | 503.7 Million | 643.6 Million | 507.64 Million | 67.99 Million | -151.28 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -59.48 Million | -20.1 Million | -164.11 Million | -23.62 Million | 128.7 Million | 155.4 Million |
Depreciation & Amortization | 127.77 Million | 108.21 Million | 136.26 Million | 456.62 Million | 114.4 Million | 99.5 Million |
Deferred income taxes | - | - | -362.82 Million | -1.06 Billion | -147.4 Million | -107.4 Million |
Stock-based compensation | 4.9 Million | 3.8 Million | 6.8 Million | 28.7 Million | 5.3 Million | 8.2 Million |
Change in working capital | 44.07 Million | -81.93 Million | -81.05 Million | -129.22 Million | -5.2 Million | -14.2 Million |
Other non-cash items | 331.92 Million | 347.83 Million | 635.69 Million | 1.39 Billion | 19.1 Million | 17.8 Million |
Investing Cash Flow | -171.52 Million | -186.66 Million | -216.15 Million | -835.85 Million | -195.1 Million | -214.4 Million |
Investments in PPE | -167.38 Million | -178.2 Million | -202.41 Million | -776.58 Million | -199.9 Million | -183.8 Million |
Acquisitions | - | - | 4.2 Million | 17.82 Million | 17 Million | -3.6 Million |
Investment purchases | -2 Million | - | -21.02 Thousand | -10.18 Million | -10 Million | - |
Sales/Maturities of investments | 5.19 Million | 4.77 Million | -1 Million | - | 1 Million | - |
Other Investing Activities | -9.32 Million | -13.24 Million | -16.92 Million | -66.9 Million | -3.2 Million | -27 Million |
Financing Cash Flow | -148.06 Million | 87.3 Million | -80.86 Million | -281.67 Million | -124.6 Million | 82.7 Million |
Debt repayment | -96.7 Million | -214.33 Million | -34.79 Million | -176.78 Million | -49.86 Million | -139.02 Million |
Dividends payments | -729.99 Thousand | -99.55 Million | -421.32 Thousand | -204.07 Million | -98.08 Million | -363.14 Thousand |
Common Stock Repurchased | -8.56 Million | -16.92 Million | -25.26 Million | -81.36 Million | -16.7 Million | -15.3 Million |
Common Stock Issuance | - | - | 12.4 Thousand | 6 Million | -3921.93 | -28.5 Million |
Other Financing Activities | -36.56 Million | -4.87 Million | -20.38 Million | 174.54 Million | 40.96 Million | 265.88 Million |
Accounts receivables | 29.05 Million | -17.72 Million | -64.8 Million | -81.87 Million | -2.17 Million | 1.17 Million |
Accounts payables | 63.67 Million | -34.54 Million | -3.06 Million | -6.41 Million | -1.18 Million | 4.7 Million |
Inventory | -30.89 Million | -30.46 Million | -15.62 Million | -38.39 Million | 6.8 Million | -20.9 Million |
Other working capital | -17.76 Million | 796.42 Thousand | 2.43 Million | -2.54 Million | -8.64 Million | 824.11 Thousand |
Cash at beginning of period | 460.52 Million | 514.55 Million | 622.1 Million | 950.66 Million | 844.5 Million | 809.7 Million |
Cash at end of period | 407.94 Million | 460.52 Million | 514.55 Million | 514.55 Million | 625.1 Million | 844.5 Million |
Capital Expenditure | -167.38 Million | -178.2 Million | -202.41 Million | -776.58 Million | -199.9 Million | -183.8 Million |
Effect of forex changes on cash | -4.9 Million | -11.5 Million | 15.4 Million | 17 Million | -14.6 Million | 7.2 Million |
Net cash flow / Change in cash | -52.58 Million | -54.02 Million | -107.55 Million | -436.11 Million | -219.4 Million | 34.8 Million |
Free Cash Flow | 83.17 Million | -123.34 Million | -31.64 Million | -118.22 Million | -85 Million | -24.5 Million |
ADN
HOVS
UNICHEMLAB
600609
PTHRF
7283